Daniel E. Otzen

Active 1994–2025

170
Papers
19,329
Citations
79
h-index
161
i10-index

Citations

Citations per year for Daniel E. Otzen1911: 2 citations1989: 1 citations1993: 1 citations1994: 3 citations1995: 19 citations1996: 38 citations1997: 54 citations1998: 52 citations1999: 65 citations2000: 48 citations2001: 55 citations2002: 72 citations2003: 47 citations2004: 55 citations2005: 57 citations2006: 59 citations2007: 101 citations2008: 70 citations2009: 105 citations2010: 148 citations2011: 135 citations2012: 117 citations2013: 130 citations2014: 179 citations2015: 204 citations2016: 153 citations2017: 143 citations2018: 172 citations2019: 677 citations2020: 773 citations2021: 754 citations2022: 639 citations2023: 471 citations2024: 766 citations2025: 445 citations2026: 8 citations1912–1988: no citations, so these years are not shown1990–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,469 citing papers, 19.2% of this breakdownChina: 700 citing papers, 9.1% of this breakdownUnited Kingdom: 688 citing papers, 9% of this breakdownGermany: 464 citing papers, 6% of this breakdownIndia: 367 citing papers, 4.8% of this breakdownDenmark: 346 citing papers, 4.5% of this breakdownSweden: 306 citing papers, 4% of this breakdownItaly: 296 citing papers, 3.9% of this breakdownFrance: 236 citing papers, 3.1% of this breakdownSpain: 215 citing papers, 2.8% of this breakdownSwitzerland: 207 citing papers, 2.7% of this breakdownAustralia: 182 citing papers, 2.4% of this breakdown
0%19.2%Other 28.5%

Fields

  • Biochemistry, Genetics and Molecular Biology38.5%
  • Medicine37.7%
  • Materials Science7.2%
  • Agricultural and Biological Sciences3.2%
  • Neuroscience2.2%
  • Chemistry2%
  • Other9.2%

Topics

  • Alzheimer's disease research and treatments10.4%
  • Protein Structure and Dynamics7.6%
  • Parkinson's Disease Mechanisms and Treatments4.7%
  • Enzyme Structure and Function3.3%
  • Prion Diseases and Protein Misfolding2.3%
  • Supramolecular Self-Assembly in Materials2.2%
  • Other69.5%

Coauthors

All papers

Open in search
  1. Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 1,447

  2. Half a century of amyloids: past, present and future

    Authors: , , , , , , , , , , , , , , - Chemical Society Reviews 2020 cited by 577

  3. ThT 101: a primer on the use of thioflavin T to investigate amyloid formation

    Authors: , , , , , , - Amyloid 2017 cited by 438

  4. Functional Amyloids

    Authors: , - Cold Spring Harbor Perspectives in Biology 2019 cited by 317

  5. Protein drug stability: a formulation challenge

    Authors: , - Nature Reviews Drug Discovery 2005 cited by 1,101

  6. α‐synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities

    Authors: , , , - Journal of Neurochemistry 2019 cited by 307

  7. The Antimicrobial Mechanism of Action of Epsilon-Poly- l -Lysine

    Authors: , , , , , - Applied and Environmental Microbiology 2014 cited by 335

  8. Protein–surfactant interactions: A tale of many states

    Authors: - Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2011 cited by 633

  9. Functional amyloid in Pseudomonas

    Authors: , , , , , , , , , , - Molecular Microbiology 2010 cited by 302

  10. Uncovering the universality of self-replication in protein aggregation and its link to disease

    Authors: , , , , , , , , , , - Science Advances 2022 cited by 59

  11. Functional bacterial amyloid increases Pseudomonas biofilm hydrophobicity and stiffness

    Authors: , , , , , , , , - Frontiers in Microbiology 2015 cited by 168

  12. Alterations in Blood Monocyte Functions in Parkinson's Disease

    Authors: , , , , , , , , - Movement Disorders 2019 cited by 93

  13. Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition

    Authors: , , , , , , , , - Journal of Biological Chemistry 2022 cited by 50

  14. Cell-Penetrating Peptides: Promising Therapeutics and Drug-Delivery Systems for Neurodegenerative Diseases

    Authors: , , , , , , , , , , , - Molecular Pharmaceutics 2024 cited by 42

  15. The Role of Stable α-Synuclein Oligomers in the Molecular Events Underlying Amyloid Formation

    Authors: , , , , , , , , , , , , , , - Journal of the American Chemical Society 2014 cited by 257

  16. Expression of Fap amyloids in Pseudomonas aeruginosa,P. fluorescens, and P. putida results in aggregation and increased biofilm formation

    Authors: , , , , , , , , , - MicrobiologyOpen 2013 cited by 167

  17. Extracellular G-quadruplexes and Z-DNA protect biofilms from DNase I, and G-quadruplexes form a DNAzyme with peroxidase activity

    Authors: , , , , , , , - Nucleic Acids Research 2024 cited by 44

  18. Sequential pH-driven dimerization and stabilization of the N-terminal domain enables rapid spider silk formation

    Authors: , , , , , , , , , , , , , , , , - Nature Communications 2014 cited by 172

  19. How Epigallocatechin Gallate Can Inhibit α-Synuclein Oligomer Toxicity in Vitro

    Authors: , , , , , , , , , , , - Journal of Biological Chemistry 2014 cited by 203

  20. Accelerated Amyloid Beta Pathogenesis by Bacterial Amyloid FapC

    Authors: , , , , , , , , , , - Advanced Science 2020 cited by 82

  21. Functional Bacterial Amyloids: Understanding Fibrillation, Regulating Biofilm Fibril Formation and Organizing Surface Assemblies

    Authors: , , - Molecules 2022 cited by 62

  22. Functional Amyloids: The Biomaterials of Tomorrow?

    Authors: , , , - Advanced Materials 2024 cited by 40

  23. Aggregation and fibrillation of bovine serum albumin

    Authors: , , , , , , , , , - Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2007 cited by 281

  24. Physical Determinants of Amyloid Assembly in Biofilm Formation

    Authors: , , , , , , , , , - mBio 2019 cited by 93